Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.

Clinical and vaccine immunology : CVI - 1 Jul 2006

Beernink Peter T, Leipus Arunas, Granoff Dan M

Abstract excerpt

The most important antigen component of a promising multicomponent group B meningococcal recombinant protein vaccine is based on genome-derived neisserial antigen 1870, which recently was renamed factor H-binding protein (FHBP) to reflect one of its critical functions as a complement regulatory protein. Neisseria meningitidis strains can be subdivided into three FHBP variant groups based on divergence of FHBP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Bacterial
Share to Bacterial Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bacterial Typing Techniques

Share to Complement Factor H

Share to Meningococcal Infections

Share to Meningococcal Vaccines

Share to Neisseria meningitidis, Serogroup B

Share to Time Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 16829612
DOI: 10.1128/CVI.00097-06
PMCID: PMC1489572

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.PMID 16829612Read ↗

Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.Semantic proximity Read ↗

Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups.Semantic proximity Read ↗

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.Semantic proximity Read ↗

Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.Semantic proximity Read ↗

Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.Semantic proximity Read ↗

Conservation of Meningococcal Antigens in the Genus <i>Neisseria</i>Semantic proximity Read ↗

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.Semantic proximity Read ↗

Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution.Semantic proximity Read ↗

Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years; Vaccine Efficiency PrognosisSemantic proximity Read ↗

Meningococcal factor H binding protein as immune evasion factor and vaccine antigenSemantic proximity Read ↗

A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H–Binding Proteins and Implications for Vaccine Coverage in Different Age GroupsSemantic proximity Read ↗

Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.